45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published: assessment threshold met
○Gross / standard charges: below assessment threshold
○Discounted cash price: below assessment threshold
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
9,483
Insurances with rates
12
CPT / HCPCS codes
8,729
Most expensive procedures (gross)
0204
$1,800
C ROOM INTENSIVE CARE PSYCH BEHAVIORAL
Gross
$4,500
0124
$1,400
C ROOM PSYCH BEHAVIORAL
Gross
$3,500
0225U
$1,251
C INFECTIOUS DISEASE PATHOGEN-SPECIFIC DNA,RNA,21 TARGETS INC ACUTE RESP SYNDROME CORONAVIRUS,AMP PR
Gross
$3,128
M0249
$541
HC ADMINISTRATION TOCILIZUMAB COVID-19 FIRST DOSE
Gross
$1,352
M0250
$541
HC ADMINISTRATION TOCILIZUMAB COVID-19 SECOND DOSE
Gross
$1,352
0636
$503
PENICILLIN G BENZATHINE 2400000 UNIT/4ML SUSY
Gross
$1,257
87631
$428
C INFECT AGENT DETECT-NUCL ACID;RESP VIRUS,MULT REVERS TRANS & AMP PRBE TECH,MULT TYPES/SUB,3-5 TARG
Gross
$1,070
87636
$428
C INFECTIOUS AGENT DETECTION NUCLEIC ACID (DNA OR RNA)SEVERE ACUTE RESPIRATORY SYNDROME SARS-COV-2 A
Gross
$1,070
87637
$428
O INFLUENZA A,INFLUENZA B, RSV AND COVID 19 PCR
Gross
$1,070
87505
$385
O STOOL PATHOGEN SCREEN BY PCR
Gross
$963
99151
$262
HC MOD SED SVC SAME MD <5Y INITIAL 15 MIN
Gross
$654
92523
$260
C ST-EVAL SPEECH SOUND PROD W/LANG COMPHRHEN
Gross
$651
87536
$256
O HIV 1 RNA QN
Gross
$639
70110
$224
C XR MANDIBLE 4+ VIEW COMPLETE
Gross
$561
70150
$224
C XR FACIAL BONES 3+ VIEW COMPLETE
Gross
$561
70200
$224
C XR ORBITS 4+ VIEW COMPLETE
Gross
$561
70250
$224
C XR SKULL < 4 VIEW LIMITED
Gross
$561
70260
$224
C XR SKULL 4+ VIEW COMPLETE
Gross
$561
71101
$224
C XR RIBS UNILATERAL 3+ VIEW WITH CHEST
Gross
$561
71110
$224
C XR RIBS BILATERAL 3 VIEW NO CHEST
Gross
$561
71111
$224
C XR RIBS BILATERAL 4+ VIEW WITH CHEST
Gross
$561
72070
$224
C XR TSPINE 2 VIEW - AP, LAT
Gross
$561
72072
$224
C XR TSPINE 3 VIEW, COMPLETE
Gross
$561
72074
$224
C XR TSPINE 4+ VIEW W/ OBLIQUES
Gross
$561
72100
$224
C XR LSPINE 2-3 VIEW - AP, LAT
Gross
$561
72110
$224
C XR LSPINE 4+ VIEW
Gross
$561
72114
$224
HC XR LSPINE W/ BENDING, MINIMUM OF 6 VIEWS
Gross
$561
72120
$224
C XR LSPINE BENDING 2 OR 3 VIEWS
Gross
$561
72190
$224
C XR PELVIS 3+ VIEW, COMPLETE (SPECIFY VIEWS)
Gross
$561
72200
$224
C XR SACROILLIAC < 3 VIEW
Gross
$561
72202
$224
C XR SACROILLIAC 3+ VIEW
Gross
$561
73010
$224
C XR SCAPULA
Gross
$561
73564
$224
C XR KNEE 4+ VIEW, COMPLETE (SPECIFY VIEW 3 & 4)
Gross
$561
74022
$224
C RADIOLOGIC EXAMINATION, COMPLETE ACUTE ABDOMEN SERIES, INCLUDING 2 OR MORE VIEWS OF THE ABDOMEN (E
Gross
$561
77073
$224
C XR BONE LENGTH STUDY
Gross
$561
72050
$224
HC XR CSPINE 4 OR 5 VIEWS (SPECIFY VIEWS)
Gross
$561
72052
$224
HC XR CSPINE +6 VIEWS
Gross
$561
73503
$224
C XR HIP,UNILATERAL W/PELVIS (WHEN PERFORMED):MIN 4 VIEWS
Gross
$561
73521
$224
C XR HIP,BILATERAL W/PELVIS (WHEN PERFORMED):2 VIEWS
Gross
$561
73522
$224
C XR HIP,BILATERAL W/PELVIS (WHEN PERFORMED):3-4 VIEWS
Gross
$561
73523
$224
C XR HIP,BILATERAL W/PELVIS (WHEN PERFORMED):MIN 5 VIEWS
Gross
$561
74019
$224
C XR ABDOMEN 2 VIEWS
Gross
$561
71048
$224
C XR CHEST SINGLE 4 OR MORE VIEWS
Gross
$561
94640
$221
C RT-M-D INHALER INITIAL
Gross
$552
92610
$218
HC ST-EVAL SWALLOWING
Gross
$546
81596
$217
C CHRONIC HCV INFECT,6 BIOCHEMICAL ASSAYS UTILIZE SERUM,REPORTD SCORES FIBROSIS/NECRO ACTIVITY LIVER
Gross
$542
87494
$211
PR INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); CHLAMYDIA TRACHOMATIS AND NEISSERIA GONO
Gross
$527
87801
$211
C MYCOPLASMA DNA DETECTION BY PCR
Gross
$527
97167
$209
C OT EVAL HIGH COMPLEXITY
Gross
$523
80050
$196
O GENERAL HEALTH PANEL
Gross
$491
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 0204 | C ROOM INTENSIVE CARE PSYCH BEHAVIORAL | $4,500 | $1,800 | — | — | 2 |
| 0124 | C ROOM PSYCH BEHAVIORAL | $3,500 | $1,400 | — | — | 10 |
| 0225U | C INFECTIOUS DISEASE PATHOGEN-SPECIFIC DNA,RNA,21 TARGETS INC ACUTE RESP SYNDROME CORONAVIRUS,AMP PR | $3,128 | $1,251 | — | — | 1 |
| M0249 | HC ADMINISTRATION TOCILIZUMAB COVID-19 FIRST DOSE | $1,352 | $541 | — | — | 1 |
| M0250 | HC ADMINISTRATION TOCILIZUMAB COVID-19 SECOND DOSE | $1,352 | $541 | — | — | 1 |
| 0636 | PENICILLIN G BENZATHINE 2400000 UNIT/4ML SUSY | $1,257 | $503 | — | — | 0 |
| 87631 | C INFECT AGENT DETECT-NUCL ACID;RESP VIRUS,MULT REVERS TRANS & AMP PRBE TECH,MULT TYPES/SUB,3-5 TARG | $1,070 | $428 | — | — | 0 |
| 87636 | C INFECTIOUS AGENT DETECTION NUCLEIC ACID (DNA OR RNA)SEVERE ACUTE RESPIRATORY SYNDROME SARS-COV-2 A | $1,070 | $428 | — | — | 1 |
| 87637 | O INFLUENZA A,INFLUENZA B, RSV AND COVID 19 PCR | $1,070 | $428 | — | — | 1 |
| 87505 | O STOOL PATHOGEN SCREEN BY PCR | $963 | $385 | — | — | 0 |
| 99151 | HC MOD SED SVC SAME MD <5Y INITIAL 15 MIN | $654 | $262 | — | — | 0 |
| 92523 | C ST-EVAL SPEECH SOUND PROD W/LANG COMPHRHEN | $651 | $260 | — | — | 1 |
| 87536 | O HIV 1 RNA QN | $639 | $256 | — | — | 0 |
| 70110 | C XR MANDIBLE 4+ VIEW COMPLETE | $561 | $224 | — | — | 1 |
| 70150 | C XR FACIAL BONES 3+ VIEW COMPLETE | $561 | $224 | — | — | 1 |
| 70200 | C XR ORBITS 4+ VIEW COMPLETE | $561 | $224 | — | — | 1 |
| 70250 | C XR SKULL < 4 VIEW LIMITED | $561 | $224 | — | — | 1 |
| 70260 | C XR SKULL 4+ VIEW COMPLETE | $561 | $224 | — | — | 1 |
| 71101 | C XR RIBS UNILATERAL 3+ VIEW WITH CHEST | $561 | $224 | — | — | 1 |
| 71110 | C XR RIBS BILATERAL 3 VIEW NO CHEST | $561 | $224 | — | — | 1 |
| 71111 | C XR RIBS BILATERAL 4+ VIEW WITH CHEST | $561 | $224 | — | — | 1 |
| 72070 | C XR TSPINE 2 VIEW - AP, LAT | $561 | $224 | — | — | 1 |
| 72072 | C XR TSPINE 3 VIEW, COMPLETE | $561 | $224 | — | — | 1 |
| 72074 | C XR TSPINE 4+ VIEW W/ OBLIQUES | $561 | $224 | — | — | 1 |
| 72100 | C XR LSPINE 2-3 VIEW - AP, LAT | $561 | $224 | — | — | 1 |
| 72110 | C XR LSPINE 4+ VIEW | $561 | $224 | — | — | 1 |
| 72114 | HC XR LSPINE W/ BENDING, MINIMUM OF 6 VIEWS | $561 | $224 | — | — | 1 |
| 72120 | C XR LSPINE BENDING 2 OR 3 VIEWS | $561 | $224 | — | — | 1 |
| 72190 | C XR PELVIS 3+ VIEW, COMPLETE (SPECIFY VIEWS) | $561 | $224 | — | — | 1 |
| 72200 | C XR SACROILLIAC < 3 VIEW | $561 | $224 | — | — | 1 |
| 72202 | C XR SACROILLIAC 3+ VIEW | $561 | $224 | — | — | 1 |
| 73010 | C XR SCAPULA | $561 | $224 | — | — | 1 |
| 73564 | C XR KNEE 4+ VIEW, COMPLETE (SPECIFY VIEW 3 & 4) | $561 | $224 | — | — | 1 |
| 74022 | C RADIOLOGIC EXAMINATION, COMPLETE ACUTE ABDOMEN SERIES, INCLUDING 2 OR MORE VIEWS OF THE ABDOMEN (E | $561 | $224 | — | — | 1 |
| 77073 | C XR BONE LENGTH STUDY | $561 | $224 | — | — | 1 |
| 72050 | HC XR CSPINE 4 OR 5 VIEWS (SPECIFY VIEWS) | $561 | $224 | — | — | 1 |
| 72052 | HC XR CSPINE +6 VIEWS | $561 | $224 | — | — | 1 |
| 73503 | C XR HIP,UNILATERAL W/PELVIS (WHEN PERFORMED):MIN 4 VIEWS | $561 | $224 | — | — | 1 |
| 73521 | C XR HIP,BILATERAL W/PELVIS (WHEN PERFORMED):2 VIEWS | $561 | $224 | — | — | 1 |
| 73522 | C XR HIP,BILATERAL W/PELVIS (WHEN PERFORMED):3-4 VIEWS | $561 | $224 | — | — | 1 |
| 73523 | C XR HIP,BILATERAL W/PELVIS (WHEN PERFORMED):MIN 5 VIEWS | $561 | $224 | — | — | 1 |
| 74019 | C XR ABDOMEN 2 VIEWS | $561 | $224 | — | — | 1 |
| 71048 | C XR CHEST SINGLE 4 OR MORE VIEWS | $561 | $224 | — | — | 1 |
| 94640 | C RT-M-D INHALER INITIAL | $552 | $221 | — | — | 1 |
| 92610 | HC ST-EVAL SWALLOWING | $546 | $218 | — | — | 1 |
| 81596 | C CHRONIC HCV INFECT,6 BIOCHEMICAL ASSAYS UTILIZE SERUM,REPORTD SCORES FIBROSIS/NECRO ACTIVITY LIVER | $542 | $217 | — | — | 1 |
| 87494 | PR INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); CHLAMYDIA TRACHOMATIS AND NEISSERIA GONO | $527 | $211 | — | — | 0 |
| 87801 | C MYCOPLASMA DNA DETECTION BY PCR | $527 | $211 | — | — | 0 |
| 97167 | C OT EVAL HIGH COMPLEXITY | $523 | $209 | — | — | 1 |
| 80050 | O GENERAL HEALTH PANEL | $491 | $196 | — | — | 0 |
Showing top 50 of 9,483 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.